SRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Stoneridge Inc (SRI) is not a strong buy for a beginner, long-term investor at this time. The company is facing financial challenges, with declining revenue and gross margin, and its recent analyst downgrade reflects skepticism about its ability to meet expectations. Additionally, hedge funds are selling the stock, and there are no significant positive catalysts or trading signals to support an immediate buy decision. The technical indicators suggest the stock is overbought, and the options data reflects bearish sentiment. Given the investor's preference for long-term investments and the lack of strong growth indicators, it is better to hold off on investing in this stock for now.
The MACD histogram is positive and expanding, indicating bullish momentum. However, the RSI is at 89.561, signaling that the stock is overbought. Moving averages are converging, suggesting indecision in price movement. The stock is trading near its resistance level of R2: 7.055, which could act as a barrier to further price increases.
No significant positive catalysts identified.
Hedge funds are selling the stock, with a 725.81% increase in selling activity over the last quarter. Analysts have downgraded the stock to Market Perform due to disappointing financial results and uncertainty about the new leadership's ability to deliver consistent performance.
In Q4 2025, revenue dropped by 6.00% YoY to $205.15M. Net income improved significantly but remains negative at -$76.91M, up 1157.92% YoY. EPS also improved but is still negative at -2.76, up 1154.55% YoY. Gross margin declined to 16.21%, down 17.92% YoY, indicating cost pressures or inefficiencies.
Barrington downgraded Stoneridge to Market Perform from Outperform, citing disappointing Q4 EBITDA results and reduced expectations for 2026. The analyst is cautious about the company's ability to meet future expectations under new leadership.
